• Publications
  • Influence
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.
BACKGROUND/AIMS We conducted a retrospective cohort study to investigate factors to early and late phase recurrence of hepatocellular carcinoma (HCC). METHODS The study population consisted of 249Expand
  • 1,038
  • 36
Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan †
  • I. Ikai, S. Arii, +9 authors M. Kudo
  • Medicine
  • Hepatology research : the official journal of the…
  • 1 September 2007
In the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan, 18 213 individuals were newly registered as patients with primary liver cancer at 645 medical institutions over a period of 2Expand
  • 353
  • 21
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
BACKGROUND & AIMS To elucidate the survival of the patients with unresectable hepatocellular carcinoma (HCC) who underwent transcatheter arterial lipiodol chemoembolization (TACE) and to analyze theExpand
  • 669
  • 20
Staging of Hepatocellular Carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM Systems in a Cohort of 13,772 Patients in Japan
Objective:The aims of this study were to present evidence to develop and validate the Japanese Tumor-Node-Metastasis (TNM) staging system for primary liver cancer and to compare its discriminatoryExpand
  • 255
  • 19
  • PDF
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
Advances in the diagnosis and surgical treatment of hepatocellular carcinoma (HCC) have improved the prognosis for patients with HCC who undergo liver resection. The objective of this study was toExpand
  • 375
  • 18
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
Objectives:To evaluate the prognostic impact of anatomic versus nonanatomic resection on the patients’ survival after resection of a single hepatocellular carcinoma (HCC). Summary of BackgroundExpand
  • 505
  • 15
Preoperative portal vein embolization: An audit of 84 patients
Preoperative portal vein embolization (PVE) was performed in 84 patients before extensive liver resection for various diseases. By the criteria of liver volumetric determination, some patients wereExpand
  • 320
  • 14
Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
The Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC), the first evidence‐based guidelines for the treatment of HCC in Japan, were compiled by an expert panel supported by the JapaneseExpand
  • 272
  • 14
Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines)
The 3rd version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine, which wasExpand
  • 270
  • 14
  • PDF
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
Background:This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreaticExpand
  • 311
  • 10